Trial of Etanercept and Methotrexate with Radiographic and Patient Outcomes two-year clinical and radiographic results: Comment on the article by van der Heijde et al [3]

Arthritis and Rheumatism

Volumn 54, Issue 9, 2006, Pages 3061-3062

  Yazici, Yusuf ^a   Yazici, Hasan ^b  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; METHOTREXATE;

BONE RADIOGRAPHY; CLINICAL TRIAL; DRUG TREATMENT FAILURE; FOLLOW UP; HUMAN; LETTER; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT INDICATION; TREATMENT OUTCOME;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOGLOBULIN G; METHOTREXATE; RANDOMIZED CONTROLLED TRIALS; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT OUTCOME;

EID: 33749352642     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22121     Document Type: Letter

References (3)

1. Van der Heijde D, Klareskog L, Rodriguez-Valverde V, Codreanu C, Bolosiu H, Melo-Gomes J, et al, for the TEMPO Study Investigators. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial. Arthritis Rheum 2006;54:1063-74.
2. Klareskog L, van der Heijde D, de Jager JP, Gough A, Kalden J, Malaise M, et al, TEMPO (Trial) of Etanercept and Methotrexate with Radiographic Patient Outcomes Study Investigators. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double blind randomized controlled trial. Lancet 2004;363:675-81.
3. Landewe R, van der Heijde D. Follow up studies in rheumatoid arthritis. Ann Rheum Dis 2002;61:479-81.